| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2728094A1 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 01/20/2010 | EP1615647B1 Pharmaceutical use of fused 1,2,4-triazoles |
| 01/19/2010 | US7649088 Diagnosis and treatment of Hereditary Spastic Paraplegia |
| 01/19/2010 | US7648999 Activator for peroxisome proliferator-activated receptor δ |
| 01/19/2010 | US7648702 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
| 01/14/2010 | WO2010006086A2 Kinase inhibitors and methods of use |
| 01/14/2010 | WO2010005565A2 Method of treating glycogen storage disease |
| 01/14/2010 | WO2010004982A1 Ameliorating or therapeutic agent for dyslipidemia |
| 01/14/2010 | WO2010004283A2 Therapy |
| 01/14/2010 | US20100010054 Therapeutic agent for amyotrophic lateral sclerosis |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009408 Induction of Gene Expression Using a High Concentration Sugar Mixture |
| 01/14/2010 | US20100008918 Methods for dosing an actriib antagonist and monitoring of treated patients |
| 01/14/2010 | US20100008907 Muscle regeneration promoter |
| 01/14/2010 | CA2730106A1 Kinase inhibitors and methods of use |
| 01/13/2010 | EP2143434A1 Composition for promoting ketone compound formation |
| 01/13/2010 | EP2143431A1 Protective agent for neurocyte comprising amidino derivative as active ingredient |
| 01/13/2010 | EP2142195A1 Composition for promoting the maintenance and function of muscle-specific progenitor cells |
| 01/13/2010 | EP2063877B1 Drugs comprising at inhibitor of class i alpha mannosidase for the treatment of sarcoglycanopathies |
| 01/13/2010 | CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 01/12/2010 | US7645796 Amino acid composition promoting collagen synthesis |
| 01/12/2010 | CA2461946C Combinations for the treatment of immunoinflammatory disorders |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010001185A1 Thieno [2,3-b] pyridine compounds with mglur activity |
| 01/07/2010 | WO2009140448A8 Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 01/07/2010 | WO2009120815A9 Therapeutic compositions and methods |
| 01/07/2010 | CA2728762A1 Rna antagonists targeting hsp27 |
| 01/06/2010 | EP2141168A1 Heteroaryl derivatives |
| 01/06/2010 | EP2139478A1 Certain chemical entities, compositions and methods |
| 01/06/2010 | CN100577149C Novel lyophilization protecting agent prescription of A type botulinum toxin freeze-dried powder injection preparation for treatment |
| 01/05/2010 | US7642903 Trailer tire alert system |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642261 Treating bipolar disorder, mania, dementia, sexual dysfunction, eating disorders, fibromyalgia |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | CA2473503C Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090325982 Phosphodiesterase 4 inhibitors |
| 12/31/2009 | US20090325930 Selective estrogen receptor modulator |
| 12/31/2009 | US20090324647 Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324598 Method for the treatment of inflammatory disorders |
| 12/31/2009 | DE202009012891U1 Mittel und Einrichtung zur Wärmebehandlung mit Erd- und Bienenwachsgemisch Means and equipment for the heat treatment of earth- and beeswax mixture |
| 12/30/2009 | CN101612402A Interferon antagonist and use of Flt3L interferon |
| 12/30/2009 | CA2729054A1 Antagonists of actriib and uses for increasing red blood cell levels |
| 12/29/2009 | US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 12/29/2009 | US7638494 G-type peptides to ameliorate atherosclerosis |
| 12/29/2009 | US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 12/29/2009 | US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/29/2009 | US7638141 Generating multipotent cells from sstem cells isolated from residual cord blood; tissue engineering and regenerative medicine |
| 12/29/2009 | CA2465877C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 12/29/2009 | CA2465349C Transdermal drug for the treatment of neural paralysis and dysfunction |
| 12/29/2009 | CA2447521C Delivery of antihistamines through an inhalation route |
| 12/29/2009 | CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors |
| 12/29/2009 | CA2423296C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| 12/29/2009 | CA2415683C Indoloquinazolinones |
| 12/24/2009 | US20090318452 INHIBITORS OF p38 |
| 12/23/2009 | WO2009155056A2 Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 12/23/2009 | WO2009154230A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 12/23/2009 | WO2009115321A8 Imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators |
| 12/23/2009 | EP2135948A2 ENA nucleic acid drugs modifying splicing in mRNA precursor |
| 12/23/2009 | EP2135613A1 Remedy and diagnostic for mitochondrial dysfunction brain disease |
| 12/23/2009 | EP1421174B1 Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 12/23/2009 | CN101610777A Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 12/23/2009 | CN100572527C Medium for culturing autologous human progenitor stem cells and applications thereof |
| 12/23/2009 | CN100571710C Medicine preparation for treating severe myasthenia |
| 12/23/2009 | CA2727935A1 Preparation of controlled release skeletal muscle relaxant dosage forms |
| 12/23/2009 | CA2725008A1 Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 12/22/2009 | US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 12/22/2009 | US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/22/2009 | US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 12/22/2009 | CA2447166C Delivery of erectile dysfunction drugs through an inhalation route |
| 12/22/2009 | CA2446990C Delivery of sedative-hypnotics through an inhalation route |
| 12/22/2009 | CA2446917C Delivery of antipsychotics through an inhalation route |
| 12/22/2009 | CA2446916C Delivery of opioids through an inhalation route |
| 12/22/2009 | CA2405593C Macrolides |
| 12/22/2009 | CA2346847C Novel imidazoles with anti-inflammatory activity |
| 12/22/2009 | CA2323607C Immunological methods to modulate myostatin in vertebrate subjects |
| 12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
| 12/17/2009 | US20090312419 CREATINE -ßALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE |
| 12/17/2009 | US20090312322 Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3 |
| 12/17/2009 | US20090311792 Fibroblast growth factor (FGF23) and methods for use |
| 12/16/2009 | CN101602767A Preparation method of galanthamine |
| 12/16/2009 | CN101601789A Medicament for treating lipid storage myopathy and preparation method thereof |
| 12/16/2009 | CN101601740A Medicament for treating myasthenia gravis and preparation method thereof |
| 12/16/2009 | CN101601665A Use of 1r, 2s-methoxamine in preparing medicament for treating faecal incontinence and other conditions |
| 12/16/2009 | CN100569281C Preparation and use of compositions for treating and preventing necrosis |
| 12/15/2009 | US7632933 Corticotropin releasing factor 2 receptor agonists |
| 12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |
| 12/10/2009 | WO2009147831A1 Method and pharmaceutical composition for treatment of mental disorders |
| 12/10/2009 | WO2009147229A1 Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon |
| 12/10/2009 | WO2009147228A1 Water-soluble extracts of artemisia dracunculus (tarragon) for improvement of glucose metabolism |
| 12/10/2009 | WO2009147125A1 Dpp-iv inhibitors for use in the treatment of nafld |
| 12/10/2009 | US20090306069 Azolidinone-vinyl fused-benzene derivatives |
| 12/10/2009 | US20090305991 33 Human Secreted Proteins |
| 12/10/2009 | US20090305951 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells |